Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
8.2
88.09%
80%
—
66.67%
Every year
—
5 Years
Score8.2
Net Growth88.09%
Net Trend80%
Net Income Consistency—
Rev Growth66.67%
Rev TrendEvery year
Revenue Consistency—
Vertex Pharmaceuticals Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 6.20B to $ 12.07B and net income grew from $ 2.71B to $ 3.95B. Revenue increased in every one of those 5 years; net income in 4.
Between 2015 and 2025, revenue grew from $ 1.03B to $ 12.07B and net income went from -$ 558M to $ 3.95B. Revenue increased in every one of those 10 years; net income in 7.
Vertex Pharmaceuticals Inc currently holds a 20-year HDB Score of 6.5 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 525.73 | — |
1 Year2025-08-12 | $ 387.77 | 35.58% |
5 Years2021-08-12 | $ 194.81 | 169.87% |
10 Years2016-08-12 | $ 101.53 | 417.81% |
20 Years2006-08-11 | $ 30.39 | 17x |
30 Years1996-08-12 | $ 12.81 | 41x |
All Time1991-07-24 | $ 4.50 | 116x |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 | 30 Years1996-08-12 | All Time1991-07-24 |
|---|---|---|---|---|---|---|---|
| Price | $ 525.73 | $ 387.77 | $ 194.81 | $ 101.53 | $ 30.39 | $ 12.81 | $ 4.50 |
| Return | — | 35.58% | 169.87% | 417.81% | 17x | 41x | 116x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 12.62B | $ 4.40B | $ 7.85B |
| 2025 | $ 12.07B | $ 3.95B | $ 6.61B |
| 2024 | $ 11.02B | -$ 535M | $ 6.11B |
| 2023 | $ 9.86B | $ 3.61B | $ 11.21B |
| 2022 | $ 8.93B | $ 3.32B | $ 10.77B |
| 2021 | $ 7.57B | $ 2.34B | $ 7.52B |
| 2020 | $ 6.20B | $ 2.71B | $ 6.65B |
| 2019 | $ 4.16B | $ 1.17B | $ 3.80B |
| 2018 | $ 3.04B | $ 2.09B | $ 3.16B |
| 2017 | $ 2.48B | $ 263M | $ 2.08B |
| 2016 | $ 1.70B | -$ 112M | $ 1.43B |
| 2015 | $ 1.03B | -$ 558M | $ 1.04B |
| 2014 | $ 580M | -$ 738M | $ 1.38B |
| 2013 | $ 1.21B | -$ 445M | $ 1.46B |
| 2012 | $ 1.52B | -$ 107M | $ 1.32B |
| 2011 | $ 1.41B | $ 29M | $ 968M |
| 2010 | $ 143M | -$ 754M | $ 1.03B |
| 2009 | $ 102M | -$ 641M | $ 1.28B |
| 2008 | $ 175M | -$ 459M | $ 832M |
| 2007 | $ 199M | -$ 391M | $ 460M |
| 2006 | $ 216M | -$ 206M | $ 704M |
| 2005 | $ 160M | -$ 203M | $ 361M |
| 2004 | $ 102M | -$ 166M | $ 386M |
| 2003 | $ 69M | -$ 196M | $ 583M |
| 2002 | $ 161M | -$ 108M | $ 634M |
| 2001 | $ 167M | -$ 66M | $ 743M |
| 2000 | $ 78M | -$ 39M | $ 459M |
| 1999 | $ 61M | -$ 41M | $ 187M |
| 1998 | $ 44M | -$ 33M | $ 24M |
| 1997 | $ 43M | -$ 19M | $ 71M |
| 1996 | $ 13M | -$ 40M | $ 34M |
| 1995 | $ 22M | -$ 21M | $ 28M |
| 1994 | $ 19M | -$ 17M | $ 71M |
| 1993 | $ 27M | $ 2M | $ 28M |
| 1992 | $ 3M | -$ 8M | $ 11M |
| IPO1991 | $ 3M | -$ 5M | $ 27M |
Explore beyond VRTX
You're looking at Vertex Pharmaceuticals Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
